Entries by Chris Chapin
World AIDS Day 2020
This year, due to COVID-19, we held a virtual event via Facebook Live and Zoom. We had a panel made up of community members and staff discuss this year’s theme […]
Let’s Quit Abusing Drug Users
Check out this TED Talk about addiction – it’s by Carl Hart, Professor of Psychology and Chair of the Department of Psychology at Columbia University. You can see more information […]
Follow us on Twitter
Finally, OTC naloxone!
Grateful to all the harm reduction advocates who continued to champion this
Next step: Make sure it is accessible to those who need it most at low/no cost for true naloxone liberation https://twitter.com/Filtermag_org/status/1641058872667283456
BREAKING: The FDA has approved the first naloxone product available without a prescription. While this removes the final regulatory barrier to naloxone access, it does not on its own lower the cost.
By @kastaliamedrano:
https://filtermag.org/fda-otc-naloxone-prescription/?utm_source=twitter&utm_medium=social&utm_campaign=filter
BREAKING: The FDA has approved the first naloxone product available without a prescription. While this removes the final regulatory barrier to naloxone access, it does not on its own lower the cost.
By @kastaliamedrano:
https://filtermag.org/fda-otc-naloxone-prescription/?utm_source=twitter&utm_medium=social&utm_campaign=filter
Calling xylazine “naloxone resistant” is a bit silly, considering that it’s not an opioid and therefore not meant for it. Xylazine is almost exclusively found WITH opioids, and so if someone isn’t adequately breathing, should still be given naloxone along w other supportive care